Insider Transactions in Q2 2022 at Good Rx Holdings, Inc. (GDRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Agnes Rey Giraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,440
+44.97%
|
-
|
|
Jun 14
2022
|
Julie Mb Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,440
+32.86%
|
-
|
|
Jun 14
2022
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,440
+44.97%
|
-
|
|
Jun 01
2022
|
Douglas Joseph Hirsch Director |
BUY
Conversion of derivative security
|
Direct |
129,375
+24.67%
|
-
|
|
Jun 01
2022
|
Trevor Bezdek Chairman |
BUY
Conversion of derivative security
|
Direct |
129,375
+24.67%
|
-
|
|
Apr 01
2022
|
Andrew Slutsky President, Consumer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,988
-1.02%
|
$588,772
$19.33 P/Share
|
|
Apr 01
2022
|
Andrew Slutsky President, Consumer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+2.02%
|
-
|